Antifibrogenic role of the cannabinoid receptor CB2 in the liver

Gastroenterology

Volumn 128, Issue 3, 2005, Pages 742-755

  Julien, Boris ^a,b   Grenard, Pascale ^a,b   Teixeira Clerc, Fatima ^a,b   Van Nhieu, Jeanne Tran ^a,b,c   Li, Liying ^a,b   Karsak, Meliha ^d   Zimmer, Andreas ^d   Mallat, Ariane ^a,b,c   Lotersztajn, Sophie ^a,b,c  

^a INSERM   (France)

^b UNIVERSITÉ PARIS EST CRÉTEIL   (France)

^c HENRI MONDOR HOSPITAL   (France)

^d UNIVERSITY OF BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

2 ARACHIDONOYLGLYCEROL; CANNABINOID 2 RECEPTOR; CARBON TETRACHLORIDE; CYCLOOXYGENASE 2; ENDOCANNABINOID; METHANANDAMIDE; REACTIVE OXYGEN METABOLITE; 2-ARACHIDONYLGLYCEROL; ACYLGLYCEROL; ARACHIDONIC ACID DERIVATIVE; TETRAHYDROCANNABINOL;

ADULT; AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL GROWTH; CELL PROLIFERATION; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVITY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CELL; LIVER CIRRHOSIS; LIVER FIBROSIS; MALE; MOUSE; MYOFIBROBLAST; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; STELLATE CELL; UPREGULATION; ANIMAL; CELL CULTURE; CELL DIVISION; FIBROBLAST; LIVER; METABOLISM; MIDDLE AGED; MOUSE MUTANT; PATHOLOGY; PATHOPHYSIOLOGY; SMOOTH MUSCLE FIBER;

ADULT; AGED; ANIMALS; APOPTOSIS; ARACHIDONIC ACIDS; CELL DIVISION; CELLS, CULTURED; FEMALE; FIBROBLASTS; GLYCERIDES; HUMANS; LIVER; LIVER CIRRHOSIS; MALE; MICE; MICE, KNOCKOUT; MIDDLE AGED; MYOCYTES, SMOOTH MUSCLE; RATS; RECEPTOR, CANNABINOID, CB2; TETRAHYDROCANNABINOL;

EID: 15744388722     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2004.12.050     Document Type: Article

References (52)

1. S. Lotersztajn, B. Julien, F. Teixeira-Clerc, P. Grenard, A. Mallat Hepatic fibrosis molecular mechanisms and drug targets Ann Rev Pharmacol Toxicol 45 2005 605 628
2. T. Knittel, D. Kobold, B. Saile, A. Grundmann, K. Neubauer, F. Piscaglia, G. Ramadori Rat liver myofibroblasts and hepatic stellate cells different cell populations of the fibroblast lineage with fibrogenic potential Gastroenterology 117 1999 1205 1221
3. D. Cassiman, T. Roskams Beauty is in the eye of the beholder emerging concepts and pitfalls in hepatic stellate cell research J Hepatol 37 2002 527 535
4. R.G. Pertwee Pharmacology of cannabinoid receptor ligands Curr Med Chem 6 1999 635 664
5. D. Piomelli, A. Giuffrida, A. Calignano, F. Rodriguez de Fonseca The endocannabinoid system as a target for therapeutic drugs Trends Pharmacol Sci 21 2000 218 224
6. Z. Jarai, J.A. Wagner, K. Varga, K.D. Lake, D.R. Compton, B.R. Martin, A.M. Zimmer, T.I. Bonner, N.E. Buckley, E. Mezey, R.K. Razdan, A. Zimmer, G. Kunos Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors Proc Natl Acad Sci U S A 96 1999 14136 14141
7. R.N. Kumar, W.A. Chambers, R.G. Pertwee Pharmacological actions and therapeutic uses of cannabis and cannabinoids Anaesthesia 56 2001 1059 1068
8. M. Bifulco, C. Laezza, G. Portella, M. Vitale, P. Orlando, L. De Petrocellis, V. Di Marzo Control by the endogenous cannabinoid system of ras oncogene-dependent tumor growth FASEB J 15 2001 2745 2747
9. M.L. Casanova, C. Blazquez, J. Martinez-Palacio, C. Villanueva, M.J. Fernandez-Acenero, J.W. Huffman, J.L. Jorcano, M. Guzman Inhibition of skin tumor growth and angiogenesis in vivo by activation of cannabinoid receptors J Clin Invest 111 2003 43 50
10. M. Guzman, C. Sanchez Effects of cannabinoids on energy metabolism Life Sci 65 1999 657 664
11. S. Batkai, Z. Jarai, J.A. Wagner, S.K. Goparaju, K. Varga, J. Liu, L. Wang, F. Mirshahi, A.D. Khanolkar, A. Makriyannis, R. Urbaschek, N. Garcia Jr, A.J. Sanyal, G. Kunos Endocannabinoids acting at vascular CB1 receptors mediate the vasodilated state in advanced liver cirrhosis Nat Med 7 2001 827 832
12. M. Rinaldi-Carmona, F. Barth, J. Millan, J.M. Derocq, P. Casellas, C. Congy, D. Oustric, M. Sarran, M. Bouaboula, B. Calandra, M. Portier, D. Shire, J.C. Breliere, G.L. Le Fur SR 144528, the first potent and selective antagonist of the CB2 cannabinoid receptor J Pharmacol Exp Ther 284 1998 644 650
13. L. Li, P. Grenard, J.T. Nhieu, B. Julien, A. Mallat, A. Habib, S. Lotersztajn Heme oxygenase-1 is an antifibrogenic protein in human hepatic myofibroblasts Gastroenterology 125 2003 460 469
14. K.M. Win, F. Charlotte, A. Mallat, D. Cherqui, N. Martin, P. Mavier, A.M. Preaux, D. Dhumeaux, J. Rosenbaum Mitogenic effect of transforming growth factor-β 1 on human Ito cells in culture evidence for mediation by endogenous platelet-derived growth factor Hepatology 18 1993 137 145
15. J. Davaille, L. Li, A. Mallat, S. Lotersztajn Sphingosine 1-phosphate triggers both apoptotic and survival signals for human hepatic myofibroblasts J Biol Chem 277 2002 37323 37330
16. J. Davaille, C. Gallois, A. Habib, L. Li, A. Mallat, J. Tao, T. Levade, S. Lotersztajn Antiproliferative properties of sphingosine 1-phosphate in human hepatic myofibroblasts A cyclooxygenase-2 mediated pathway J Biol Chem 275 2000 34628 34633
17. D. Vrochides, V. Papanikolaou, H. Pertoft, A.A. Antoniades, P. Heldin Biosynthesis and degradation of hyaluronan by nonparenchymal liver cells during liver regeneration Hepatology 23 1996 1650 1655
18. M.W. Pfaffl, G.W. Horgan, L. Dempfle Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR Nucleic Acids Res 30 2002 e36
19. C. Gallois, A. Habib, J. Tao, S. Moulin, J. Maclouf, A. Mallat, S. Lotersztajn Role of NF-κB in the antiproliferative effect of endothelin-1 and tumor necrosis factor-α in human hepatic stellate cells Involvement of cyclooxygenase-2 J Biol Chem 273 1998 23183 23190
20. L. Li, J. Tao, J. Davaille, C. Feral, A. Mallat, J. Rieusset, H. Vidal, S. Lotersztajn 15-Deoxy-delta 12,14-prostaglandin j2 induces apoptosis of human hepatic myofibroblasts, a pathway involving oxidative stress independently of peroxisome-proliferator-activated receptors J Biol Chem 276 2001 38152 38158
21. J. Tao, A. Mallat, C. Gallois, S. Belmadani, P.F. Méry, J.T. Nhieu, C. Pavoine, S. Lotersztajn Biological effects of C-type natriuretic peptide in human myofibroblastic hepatic stellate cells J Biol Chem 274 1999 23761 23769
22. N.E. Buckley, K.L. McCoy, E. Mezey, T. Bonner, A. Zimmer, C.C. Felder, M. Glass, A. Zimmer Immunomodulation by cannabinoids is absent in mice deficient for the cannabinoid CB(2) receptor Eur J Pharmacol 396 2000 141 149
23. P. Grenard, B. Blanquier, S. Ricard-Blum Urinary excretion of the collagen cross-link pyridinoline increases during liver fibrogenesis J Hepatol 26 1997 1356 1362
24. J.F. Woessner Jr The determination of hydroxyproline in tissue and protein samples containing small proportions of this imino acid Arch Biochem Biophys 93 1961 440 447
25. L.B. Creemers, D.C. Jansen, A. van Veen-Reurings, T. van den Bos, V. Everts Microassay for the assessment of low levels of hydroxyproline Biotechniques 22 1997 656 658
26. A. Mallat, L. Fouassier, A.M. Preaux, C.S. Gal, D. Raufaste, J. Rosenbaum, D. Dhumeaux, C. Jouneaux, P. Mavier, S. Lotersztajn Growth inhibitory properties of endothelin-1 in human hepatic myofibroblastic Ito cells An endothelin B receptor-mediated pathway J Clin Invest 96 1995 42 49
27. A. Mallat, C. Gallois, J. Tao, A. Habib, J. Maclouf, P. Mavier, A.M. Preaux, S. Lotersztajn Platelet-derived growth factor-BB and thrombin generate positive and negative signals for human hepatic stellate cell proliferation Role of a prostaglandin/cyclic AMP pathway and cross-talk with endothelin receptors J Biol Chem 273 1998 27300 27305
28. S. Melov, J. Ravenscroft, S. Malik, M.S. Gill, D.W. Walker, P.E. Clayton, D.C. Wallace, B. Malfroy, S.R. Doctrow, G.J. Lithgow Extension of life-span with superoxide dismutase/catalase mimetics Science 289 2000 1567 1569
29. D.G. Deutsch, M.S. Goligorsky, P.C. Schmid, R.J. Krebsbach, H.H. Schmid, S.K. Das, S.K. Dey, G. Arreaza, C. Thorup, G. Stefano, L.C. Moore Production and physiological actions of anandamide in the vasculature of the rat kidney J Clin Invest 100 1997 1538 1546
30. M. Guzman, C. Sanchez, I. Galve-Roperh Control of the cell survival/death decision by cannabinoids J Mol Med 78 2001 613 625
31. A. Sanchez, A.M. Alvarez, M. Benito, I. Fabregat Apoptosis induced by transforming growth factor-β in fetal hepatocyte primary cultures involvement of reactive oxygen intermediates J Biol Chem 271 1996 7416 7422
32. L. Li, B. Julien, P. Grenard, F. Teixeira-Clerc, A. Mallat, S. Lotersztajn Molecular mechanisms regulating the antifibrogenic protein heme oxygenase-1 in human hepatic myofibroblasts J Hepatol 41 2004 407 413
33. R.J. McKallip, C. Lombard, M. Fisher, B.R. Martin, S. Ryu, S. Grant, P.S. Nagarkatti, M. Nagarkatti Targeting CB2 cannabinoid receptors as a novel therapy to treat malignant lymphoblastic disease Blood 100 2002 627 634
34. A. Ligresti, T. Bisogno, I. Matias, L. De Petrocellis, M.G. Cascio, V. Cosenza, G. D'Argenio, G. Scaglione, M. Bifulco, I. Sorrentini, V. Di Marzo Possible endocannabinoid control of colorectal cancer growth Gastroenterology 125 2003 677 687
35. L. De Petrocellis, D. Melck, A. Palmisano, T. Bisogno, C. Laezza, M. Bifulco, V. Di Marzo The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation Proc Natl Acad Sci U S A 95 1998 8375 8380
36. S. Hilairet, M. Bouaboula, D. Carriere, G. Le Fur, P. Casellas Hypersensitization of the Orexin 1 receptor by the CB1 receptor evidence for cross-talk blocked by the specific CB1 antagonist, SR141716 J Biol Chem 278 2003 23731 23737
37. S. Martin, V. Navarro, J.P. Vincent, J. Mazella Neurotensin receptor-1 and -3 complex modulates the cellular signaling of neurotensin in the HT29 cell line Gastroenterology 123 2002 1135 1143
38. K.K. Biswas, K.P. Sarker, K. Abeyama, K. Kawahara, S. Iino, Y. Otsubo, K. Saigo, H. Izumi, T. Hashiguchi, M. Yamakuchi, K. Yamaji, R. Endo, K. Suzuki, H. Imaizumi, I. Maruyama Membrane cholesterol but not putative receptors mediates anandamide-induced hepatocyte apoptosis Hepatology 38 2003 1167 1177
39. S. Kojima, T. Sugiura, K. Waku, Y. Kamikawa Contractile response to a cannabimimetic eicosanoid, 2-arachidonoylglycerol, of longitudinal smooth muscle from the guinea-pig distal colon in vitro Eur J Pharmacol 444 2002 203 207
40. K.R. Kozak, S.W. Rowlinson, L.J. Marnett Oxygenation of the endocannabinoid, 2-arachidonylglycerol, to glyceryl prostaglandins by cyclooxygenase-2 J Biol Chem 275 2000 33744 33749
41. G.C. Chan, T.R. Hinds, S. Impey, D.R. Storm Hippocampal neurotoxicity of Δ9-tetrahydrocannabinol J Neurosci 18 1998 5322 5332
42. S.A. Hunter, S.H. Burstein Receptor mediation in cannabinoid stimulated arachidonic acid mobilization and anandamide synthesis Life Sci 60 1997 1563 1573
43. S.A. Hunter, C.A. Audette, S. Burstein Elevation of brain prostaglandin E2 levels in rodents by δ 1-tetrahydrocannabinol Prostaglandins Leukot Essent Fatty Acids 43 1991 185 190
44. R. Ramer, K. Brune, A. Pahl, B. Hinz R(+)-methanandamide induces cyclooxygenase-2 expression in human neuroglioma cells via a non-cannabinoid receptor-mediated mechanism Biochem Biophys Res Commun 286 2001 1144 1152
45. B. Gardner, L.X. Zhu, S. Sharma, D.P. Tashkin, S.M. Dubinett Methanandamide increases COX-2 expression and tumor growth in murine lung cancer FASEB J 17 2003 2157 2159
46. J.Y. Kato, M. Matsuoka, K. Polyak, J. Massague, C.J. Sherr Cyclic AMP-induced G1 phase arrest mediated by an inhibitor (p27Kip1) of cyclin-dependent kinase 4 activation Cell 79 1994 487 496
47. N. Arakaki, T. Kajihara, R. Arakaki, T. Ohnishi, J.A. Kazi, H. Nakashima, Y. Daikuhara Involvement of oxidative stress in tumor cytotoxic activity of hepatocyte growth factor/scatter factor J Biol Chem 274 1999 13541 13546
48. Y. Morel, R. Barouki Repression of gene expression by oxidative stress Biochem J 342 1999 481 496
49. M. Guzman, I. Galve-Roperh, C. Sanchez Ceramide a new second messenger of cannabinoid action Trends Pharmacol Sci 22 2001 19 22
50. N. Andrieu-Abadie, T. Levade Sphingomyelin hydrolysis during apoptosis Biochim Biophys Acta 1585 2002 126 134
51. M. Portier, M. Rinaldi-Carmona, F. Pecceu, T. Combes, C. Poinot-Chazel, B. Calandra, F. Barth, G. le Fur, P. Casellas SR 144528, an antagonist for the peripheral cannabinoid receptor that behaves as an inverse agonist J Pharmacol Exp Ther 288 1999 582 589
52. P. Grenard, B. Julien, J. Tran-Van-Nhieu, L. Li, C. Ledent, A. Mallat, S. Lotersztajn Reduced liver fibrosis in CB1 receptor knockout mice J Hepatol 40 Suppl 1 2004 8